Last 12 months
Inside the activity.
0 purchase rows · 145 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 41 |
| Apr 2026 | 0 | 26 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 11 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 18 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2023 Filed Mar 9, 2023 01:01 UTC |
RUBINSTEIN JULIEPresident
|
GrantCommon Stock | 132,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006323 · form4.xml · nonDerivative · entry 1 RUBINSTEIN JULIE · CIK 0001780664 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,492 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:00 UTC |
ROBINS HARLAN SChief Scientific Officer
|
GrantCommon Stock | 354,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006322 · form4.xml · nonDerivative · entry 1 ROBINS HARLAN S · CIK 0001780851 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,570 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:08 UTC |
Pellini Michael JDirector
|
GrantStock Option (right to buy) · Derivative | 23,329 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006337 · form4.xml · derivative · entry 2 Pellini Michael J · CIK 0001402017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:08 UTC |
Pellini Michael JDirector
|
GrantCommon Stock | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006337 · form4.xml · nonDerivative · entry 1 Pellini Michael J · CIK 0001402017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,968 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:07 UTC |
NEUPERT PETER MDirector
|
GrantStock Option (right to buy) · Derivative | 23,329 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006335 · form4.xml · derivative · entry 2 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:07 UTC |
NEUPERT PETER MDirector
|
GrantCommon Stock | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006335 · form4.xml · nonDerivative · entry 1 NEUPERT PETER M · CIK 0001237566 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,968 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:06 UTC |
HERSHBERG ROBERTDirector
|
GrantStock Option (right to buy) · Derivative | 23,329 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006334 · form4.xml · derivative · entry 2 HERSHBERG ROBERT · CIK 0001274139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:06 UTC |
HERSHBERG ROBERTDirector
|
GrantCommon Stock | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006334 · form4.xml · nonDerivative · entry 1 HERSHBERG ROBERT · CIK 0001274139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,968 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:06 UTC |
GRIFFIN MICHELLE RENEEDirector
|
GrantStock Option (right to buy) · Derivative | 23,329 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006333 · form4.xml · derivative · entry 2 GRIFFIN MICHELLE RENEE · CIK 0001229765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:06 UTC |
GRIFFIN MICHELLE RENEEDirector
|
GrantCommon Stock | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006333 · form4.xml · nonDerivative · entry 1 GRIFFIN MICHELLE RENEE · CIK 0001229765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,968 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:05 UTC |
Conroy Kevin TDirector
|
GrantStock Option (right to buy) · Derivative | 23,329 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006332 · form4.xml · derivative · entry 2 Conroy Kevin T · CIK 0001306119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:05 UTC |
Conroy Kevin TDirector
|
GrantCommon Stock | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006332 · form4.xml · nonDerivative · entry 1 Conroy Kevin T · CIK 0001306119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,968 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:05 UTC |
Trigg LeslieDirector
|
GrantStock Option (right to buy) · Derivative | 23,329 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006331 · form4.xml · derivative · entry 2 Trigg Leslie · CIK 0001304125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:05 UTC |
Trigg LeslieDirector
|
GrantCommon Stock | 14,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006331 · form4.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,907 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:03 UTC |
PETERSON TYCHOChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 177,377 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006326 · form4.xml · derivative · entry 2 PETERSON TYCHO · CIK 0001927856 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,377 Underlying: Common Stock · 177,377 shares Expires 2033-03-06 F1 · derivative.exercise_date: The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:03 UTC |
PETERSON TYCHOChief Financial Officer
|
GrantCommon Stock | 118,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006326 · form4.xml · nonDerivative · entry 1 PETERSON TYCHO · CIK 0001927856 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,891 Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:02 UTC |
BENZENO SHARONChief Commercial Ofc Imm Med
|
GrantStock Option (right to buy) · Derivative | 199,549 | $0.00 Strike: $8.46 | $0.00 |
DisclosureSEC source: 0001062993-23-006325 · form4.xml · derivative · entry 3 BENZENO SHARON · CIK 0001780854 · Chief Commercial Ofc Imm Med 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,549 Underlying: Common Stock · 199,549 shares Expires 2033-03-06 F2 · derivative.exercise_date: The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:02 UTC |
BENZENO SHARONChief Commercial Ofc Imm Med
|
SaleCommon Stock | 11,749 | $8.57 | $100,688.93 |
DisclosureSEC source: 0001062993-23-006325 · form4.xml · nonDerivative · entry 2 BENZENO SHARON · CIK 0001780854 · Chief Commercial Ofc Imm Med 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,826 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 01:02 UTC |
BENZENO SHARONChief Commercial Ofc Imm Med
|
GrantCommon Stock | 132,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006325 · form4.xml · nonDerivative · entry 1 BENZENO SHARON · CIK 0001780854 · Chief Commercial Ofc Imm Med 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,575 Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:00 UTC |
HERSHBERG ROBERTDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 53,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001209191-23-006994 · doc4.xml · derivative · entry 2 HERSHBERG ROBERT · CIK 0001274139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,000 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 22:00 UTC |
HERSHBERG ROBERTDirector
|
Exercise / conversionCommon Stock | 53,000 | $0.45 | $23,850.00 |
DisclosureSEC source: 0001209191-23-006994 · doc4.xml · nonDerivative · entry 1 HERSHBERG ROBERT · CIK 0001274139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 10, 2023 Filed Jan 11, 2023 18:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 2,130 | $8.58 | $18,275.40 |
DisclosureSEC source: 0001209191-23-003052 · doc4.xml · nonDerivative · entry 2 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,518 F2 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 18:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 995 | $8.50 | $8,457.50 |
DisclosureSEC source: 0001209191-23-003052 · doc4.xml · nonDerivative · entry 1 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,648 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 11:00 UTC |
PISKEL KYLEPrincipal Accounting Officer
|
SaleCommon Stock | 959 | $8.87 | $8,506.33 |
DisclosureSEC source: 0001209191-22-057432 · doc4.xml · nonDerivative · entry 1 PISKEL KYLE · CIK 0001780662 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,706 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:15 UTC Amendment |
PISKEL KYLEPrincipal Accounting Officer
|
SaleCommon Stock | 307 | $8.87 | $2,723.09 |
DisclosureSEC source: 0001209191-22-057531 · doc4a.xml · nonDerivative · entry 1 PISKEL KYLE · CIK 0001780662 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,358 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding olbigaitons to e funded by a sell to cover transaction and does not represent a discretionary trade. Read SEC document |
| November 01, 2022 Filed Nov 1, 2022 21:00 UTC |
SOOD NITINChief Commercial Officer, MRD
|
SaleCommon Stock | 31,066 | $8.00 | $248,528.00 |
DisclosureSEC source: 0001209191-22-055170 · doc4.xml · nonDerivative · entry 1 SOOD NITIN · CIK 0001877433 · Chief Commercial Officer, MRD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,505 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022. Read SEC document |
| October 10, 2022 Filed Oct 11, 2022 18:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 2,284 | $7.13 | $16,284.92 |
DisclosureSEC source: 0001209191-22-053372 · doc4.xml · nonDerivative · entry 2 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,643 F2 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022. Read SEC document |
| October 07, 2022 Filed Oct 11, 2022 18:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 841 | $7.61 | $6,400.01 |
DisclosureSEC source: 0001209191-22-053372 · doc4.xml · nonDerivative · entry 1 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,927 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| August 05, 2022 Filed Aug 5, 2022 20:49 UTC |
SOOD NITINChief Commercial Officer, MRD
|
SaleCommon Stock | 17,540 | $10.98 | $192,589.20 |
DisclosureSEC source: 0001209191-22-044688 · doc4.xml · nonDerivative · entry 1 SOOD NITIN · CIK 0001877433 · Chief Commercial Officer, MRD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,571 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 2,300 | $10.47 | $24,081.00 |
DisclosureSEC source: 0001209191-22-041730 · doc4.xml · nonDerivative · entry 2 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,768 F2 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2022. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 21:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 825 | $9.53 | $7,862.25 |
DisclosureSEC source: 0001209191-22-041730 · doc4.xml · nonDerivative · entry 1 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,068 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:00 UTC |
PETERSON TYCHOChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 597,157 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001209191-22-034343 · doc4.xml · derivative · entry 2 PETERSON TYCHO · CIK 0001927856 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 597,157 Underlying: Common Stock · 597,157 shares Expires 2032-06-01 F1 · derivative.exercise_date: The options vest with respect to 1/4 of such shares on June 1, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:00 UTC |
PETERSON TYCHOChief Financial Officer
|
GrantCommon Stock | 374,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034343 · doc4.xml · nonDerivative · entry 1 PETERSON TYCHO · CIK 0001927856 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,688 Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 20:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 831 | $13.17 | $10,944.27 |
DisclosureSEC source: 0001209191-22-023916 · doc4.xml · nonDerivative · entry 1 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,893 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 00:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,815 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001209191-22-017696 · doc4.xml · derivative · entry 10 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755,555 Underlying: Common Stock · 14,815 shares Expires 2025-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 00:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
SaleCommon Stock | 14,815 | $12.46 | $184,594.90 |
DisclosureSEC source: 0001209191-22-017696 · doc4.xml · nonDerivative · entry 7 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021. F5 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $12.21 to 12.73, inclusive. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 00:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 14,815 | $6.32 | $93,630.80 |
DisclosureSEC source: 0001209191-22-017696 · doc4.xml · nonDerivative · entry 6 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 00:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,815 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001209191-22-017696 · doc4.xml · derivative · entry 9 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 770,370 Underlying: Common Stock · 14,815 shares Expires 2025-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 00:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
SaleCommon Stock | 14,815 | $11.38 | $168,594.70 |
DisclosureSEC source: 0001209191-22-017696 · doc4.xml · nonDerivative · entry 5 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021. F4 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.27 to 11.55, inclusive. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 00:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 14,815 | $6.32 | $93,630.80 |
DisclosureSEC source: 0001209191-22-017696 · doc4.xml · nonDerivative · entry 4 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:00 UTC |
Taylor Stacy LSVP and General Counsel
|
SaleCommon Stock | 2,387 | $11.44 | $27,307.28 |
DisclosureSEC source: 0001209191-22-018095 · doc4.xml · nonDerivative · entry 1 Taylor Stacy L · CIK 0001799081 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,859 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.32 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:05 UTC |
LO FRANCISChief People Officer
|
SaleCommon Stock | 3,582 | $11.44 | $40,978.08 |
DisclosureSEC source: 0001209191-22-017839 · doc4.xml · nonDerivative · entry 1 LO FRANCIS · CIK 0001780660 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,588 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021. F2 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.29 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 23:00 UTC |
BALDO LANCEChief Medical Officer
|
SaleCommon Stock | 3,350 | $11.43 | $38,290.50 |
DisclosureSEC source: 0001209191-22-018021 · doc4.xml · nonDerivative · entry 1 BALDO LANCE · CIK 0001780773 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,171 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021. F2 · price: The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $11.28 to 11.65, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 02:00 UTC |
PISKEL KYLEPrincipal Accounting Officer
|
SaleCommon Stock | 220 | $12.01 | $2,642.20 |
DisclosureSEC source: 0001209191-22-017396 · doc4.xml · nonDerivative · entry 2 PISKEL KYLE · CIK 0001780662 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,665 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 21:00 UTC |
ADAMS R MARKChief Operating Officer
|
SaleCommon Stock | 1,244 | $12.01 | $14,940.44 |
DisclosureSEC source: 0001209191-22-017392 · doc4.xml · nonDerivative · entry 2 ADAMS R MARK · CIK 0001808905 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,724 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 21:00 UTC |
Taylor Stacy LSVP and General Counsel
|
SaleCommon Stock | 1,569 | $12.01 | $18,843.69 |
DisclosureSEC source: 0001209191-22-017397 · doc4.xml · nonDerivative · entry 2 Taylor Stacy L · CIK 0001799081 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,246 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 02:00 UTC |
ROBINS CHAD MDirector · CEO and Chairman
|
SaleCommon Stock | 4,424 | $12.01 | $53,132.24 |
DisclosureSEC source: 0001209191-22-017393 · doc4.xml · nonDerivative · entry 2 ROBINS CHAD M · CIK 0001780649 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,916,154 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 02:00 UTC |
LO FRANCISChief People Officer
|
SaleCommon Stock | 1,569 | $12.01 | $18,843.69 |
DisclosureSEC source: 0001209191-22-017395 · doc4.xml · nonDerivative · entry 2 LO FRANCIS · CIK 0001780660 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,170 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 02:01 UTC |
RUBINSTEIN JULIEPresident
|
SaleCommon Stock | 4,613 | $12.01 | $55,402.13 |
DisclosureSEC source: 0001209191-22-017399 · doc4.xml · nonDerivative · entry 2 RUBINSTEIN JULIE · CIK 0001780664 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,513 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 02:00 UTC |
ROBINS HARLAN SChief Scientific Officer
|
SaleCommon Stock | 4,517 | $12.01 | $54,249.17 |
DisclosureSEC source: 0001209191-22-017394 · doc4.xml · nonDerivative · entry 2 ROBINS HARLAN S · CIK 0001780851 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,960 F1 · kind: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.